Helius Medical Technologies, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: Pantera Entities Update Solana Stake
Pantera Capital entities and Daniel W. Morehead have amended their Schedule 13D filing to report the exercise of 1,000,000 warrants and their current beneficial ownership in Solana Co.
NASDAQ
SCHEDULE: Pantera Entities Adjust Solana Stake
Pantera Capital entities have amended their Schedule 13D filing to reflect an adjustment in their beneficial ownership of Solana Company's Class A Common Stock following a warrant exercise.
NASDAQ
Choon Wee Chee, Executive Chairman of Solana Company, has increased his beneficial ownership to 20.2% following the settlement of restricted stock units.
NASDAQ
Fusion Summer Limited, controlled by Executive Chairman CHEE Choon Wee, acquired 17.0% of Helius Medical Technologies' Class A Common Stock for approximately $47.0 million.
NASDAQ
Pantera Capital and its founder Daniel W. Morehead have disclosed a significant 9.67% beneficial ownership stake in Helius Medical Technologies, Inc., including common stock and pre-funded warrants.